$CTIC Recent News Insider filings one way to t
Post# of 74544
Posted On: 05/14/2014 11:50:12 AM
$CTIC Recent News
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Cell Therapeutics: Enticing To All, Convincing To None 9:10 a.m. May 7, 2014 - Seeking Alpha
Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript 10:52 p.m. April 29, 2014 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:10 p.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape 9:21 a.m. April 29, 2014 - Zacks.com
Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 9:21 a.m. April 10, 2014 - Zacks.com
Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders 10:45 a.m. March 31, 2014 - TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. March 28, 2014 - Zacks.com
First Week Of CTIC May 17th Options Trading 12:54 p.m. March 26, 2014 - TheStreet.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month 10:39 a.m. March 24, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ... 10:12 a.m. March 24, 2014 - GuruFocus.com
Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns 9:57 a.m. March 12, 2014 - TheStreet.com
Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders 1:16 p.m. March 10, 2014 - TheStreet.com
Is It Too Late to Buy the Rally in Small Caps? 12:00 a.m. March 7, 2014 - InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 9:21 p.m. March 4, 2014 - Seeking Alpha
10-K: CELL THERAPEUTICS INC 5:32 p.m. March 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment 4:49 p.m. March 4, 2014 - Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation 9:47 a.m. Feb. 27, 2014 - Seeking Alpha
Interesting CTIC Put And Call Options For April 19th 11:01 a.m. Feb. 26, 2014 - TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule 7:33 a.m. Feb. 26, 2014 - TheStreet.com
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Cell Therapeutics Reports First Quarter 2014 Financial Results 4:01 p.m. April 29, 2014 - PR Newswire - PRF
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma 1:30 a.m. April 29, 2014 - PR Newswire - PRF
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014 1:30 a.m. April 22, 2014 - PR Newswire - PRF
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics 8:00 a.m. March 18, 2014 - PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx 8:54 a.m. March 14, 2014 - PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference 2:30 a.m. March 5, 2014 - PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:00 p.m. March 4, 2014 - PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts 2:30 a.m. March 3, 2014 - PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 2:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 2:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 10:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC) 11:12 a.m. Feb. 11, 2014 - ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors 2:30 a.m. Feb. 3, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia 2:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer 2:30 a.m. Jan. 28, 2014 - PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC) 8:23 a.m. Jan. 20, 2014 - ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources 11:52 a.m. Jan. 14, 2014 - ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress 2:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Cell Therapeutics: Enticing To All, Convincing To None 9:10 a.m. May 7, 2014 - Seeking Alpha
Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript 10:52 p.m. April 29, 2014 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:10 p.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape 9:21 a.m. April 29, 2014 - Zacks.com
Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 9:21 a.m. April 10, 2014 - Zacks.com
Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders 10:45 a.m. March 31, 2014 - TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. March 28, 2014 - Zacks.com
First Week Of CTIC May 17th Options Trading 12:54 p.m. March 26, 2014 - TheStreet.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month 10:39 a.m. March 24, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ... 10:12 a.m. March 24, 2014 - GuruFocus.com
Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns 9:57 a.m. March 12, 2014 - TheStreet.com
Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders 1:16 p.m. March 10, 2014 - TheStreet.com
Is It Too Late to Buy the Rally in Small Caps? 12:00 a.m. March 7, 2014 - InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 9:21 p.m. March 4, 2014 - Seeking Alpha
10-K: CELL THERAPEUTICS INC 5:32 p.m. March 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment 4:49 p.m. March 4, 2014 - Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation 9:47 a.m. Feb. 27, 2014 - Seeking Alpha
Interesting CTIC Put And Call Options For April 19th 11:01 a.m. Feb. 26, 2014 - TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule 7:33 a.m. Feb. 26, 2014 - TheStreet.com
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Cell Therapeutics Reports First Quarter 2014 Financial Results 4:01 p.m. April 29, 2014 - PR Newswire - PRF
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma 1:30 a.m. April 29, 2014 - PR Newswire - PRF
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014 1:30 a.m. April 22, 2014 - PR Newswire - PRF
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics 8:00 a.m. March 18, 2014 - PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx 8:54 a.m. March 14, 2014 - PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference 2:30 a.m. March 5, 2014 - PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:00 p.m. March 4, 2014 - PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts 2:30 a.m. March 3, 2014 - PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 2:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 2:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 10:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC) 11:12 a.m. Feb. 11, 2014 - ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors 2:30 a.m. Feb. 3, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia 2:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer 2:30 a.m. Jan. 28, 2014 - PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC) 8:23 a.m. Jan. 20, 2014 - ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources 11:52 a.m. Jan. 14, 2014 - ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress 2:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼